title: Multimodality imaging of cardiothoracic lymphoma.
abstract: Lymphoma is the most common hematologic malignancy and represents approximately 5.3% of all cancers. The World Health Organization published a revised classification scheme in 2008 that groups lymphomas by cell type and molecular, cytogenetic, and phenotypic characteristics. Most lymphomas affect the thorax at some stage during the course of the disease. Affected structures within the chest may include the lungs, mediastinum, pleura, and chest wall, and lymphomas may originate from these sites as primary malignancies or secondarily involve these structures after arising from other intrathoracic or extrathoracic sources. Pulmonary lymphomas are classified into one of four types: primary pulmonary lymphoma, secondary pulmonary lymphoma, acquired immunodeficiency syndrome-related lymphoma, and post-transplantation lymphoproliferative disorders. Although pulmonary lymphomas may produce a myriad of diverse findings within the lungs, specific individual features or combinations of features can be used, in combination with secondary manifestations of the disease such as involvement of the mediastinum, pleura, and chest wall, to narrow the differential diagnosis. While findings of thoracic lymphoma may be evident on chest radiography, computed tomography has traditionally been the imaging modality used to evaluate the disease and effectively demonstrates the extent of intrathoracic involvement and the presence and extent of extrathoracic spread. However, additional modalities such as magnetic resonance imaging of the thorax and (18)F-FDG PET/CT have emerged in recent years and are complementary to CT in the evaluation of patients with lymphoma. Thoracic MRI is useful in assessing vascular, cardiac, and chest wall involvement, and PET/CT is more accurate in the overall staging of lymphoma than CT and can be used to evaluate treatment response.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Department of Diagnostic Radiology, Section of Thoracic Imaging, 1515 Holcombe Blvd., Unit 1478, Houston, TX 77030, USA. Electronic address: bcarter2@mdanderson.org.
authors.forename: Brett W
authors.initials: BW
authors.lastname: Carter
authors.affiliation: Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, FND-202, Boston, MA 02114, USA.
authors.forename: Carol C
authors.initials: CC
authors.lastname: Wu
authors.affiliation: Department of Radiology, Mount Auburn Hospital, Cambridge, MA 02138, USA.
authors.forename: Leila
authors.initials: L
authors.lastname: Khorashadi
authors.affiliation: The University of Texas MD Anderson Cancer Center, Department of Diagnostic Radiology, Section of Thoracic Imaging, 1515 Holcombe Blvd., Unit 1478, Houston, TX 77030, USA.
authors.forename: Myrna C B
authors.initials: MC
authors.lastname: Godoy
authors.affiliation: The University of Texas MD Anderson Cancer Center, Department of Diagnostic Radiology, Section of Thoracic Imaging, 1515 Holcombe Blvd., Unit 1478, Houston, TX 77030, USA.
authors.forename: Patricia M
authors.initials: PM
authors.lastname: de Groot
authors.affiliation: Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, FND-202, Boston, MA 02114, USA.
authors.forename: Gerald F
authors.initials: GF
authors.lastname: Abbott
authors.affiliation: Department of Radiology, David Grant Medical Center, Travis AFB, CA 94535, USA.
authors.forename: John P
authors.initials: JP
authors.lastname: Lichtenberger
mesh_terms: D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000473:pathology; D064847:Multimodal Imaging; D013899:Thoracic Neoplasms / Q000175:diagnosis* / Q000473:pathology
keywords: CT; Cardiac; Lymphoma; MRI; PET/CT; Thoracic